(CY 2332) and National Heart Institute Grant H 3923.
METHODSThyrotropic hormone preparations. Three bovine thyroid-stimulating hormone (TSH) preparations were used in these studies. One, in clinical use under the trade name Thytropar, contained approximately 1 international unit (IU) per mg ("Armour"). The two other preparations contained greater activity ranging from 5 to 25 IU per mg, and were provided through the kindness of Dr. Peter G. Condliffe and Dr. Rohert W. Bates ("Condliffe"), and Drs. John L. Pierce and M. E. Carsten ("Pierce"). Both of these latter preparations were concentrated on anion diethylaminoethyl (DEAE) and cation (carboxymethyl cellulose) exchange resins (6, 7) with some variations in methodology between laboratories. A mouse pituitary tumor thyrotropin preparation was made available by Dr. Condliffe and Dr. Bates (8) and a preparation of human thyrotropin by Dr. John Bakke and Dr. Peter Heidemann.Pituitary hormone preparations other than 'ISH. A number of pituitary hormone preparations other than TSH were tested for cross reaction with the anti-TSH sera. The sources of these preparations are listed in Table II. All preparations termed "Wilhelmi" were provided by both Dr. Alfred E. Wilhelmi and Dr. Stanley Ellis. The bovine growth hormone and prolactin preparations were obtained as a gift of the Endocrine Study Section, National Institutes of Health.Preparation of antisera. The antisera used for the precipitin and in vivro neutralization studies were developed in rabbits. Fifteen animals were immunized: 9 with Armour TSH, and 3 animals each with the Condliffe and Pierce TSH preparations, respectively. Three IU of thyrotropin was incorporated in 1.0 ml of Freund adjuvant and injected intracutaneously in multiple sites (9). The injections were repeated 2 or 3 times, at weekly or biweekly intervals. A total of 9 or 12 U was given to each rabbit. Ten days after the final injection, the animals were exsanguinated under sterile conditions and the sera were separated and stored without preservative at 40 C. After the initial precipitin studies, absorption of the antisera to TSH with bovine serum was routinely performed. This was accomplished in the following manner: 0.05 ml of bovine serum was added to each 1.0 ml of antiserum and allowed to stand 5 to 7 days at 40 C. The precipitate was then removed by centrifugation, and another 0.05 ml of bovine serum added to the supernatant. This procedure was repeated until there was no further 92